Clinical trial recruitment for ABBV-744 study Fundamentals Explained
Participant eaten grapefruit or grapefruit products within three times just before the very first dose of study drug.- "Our study disclosed the very important role of the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, for example OTX015 or ABBV-744, with